Skip to Main Content

Browse issues

The Journal of Clinical Endocrinology & Metabolism Cover Image for Volume 103, Issue 9
Volume 103, Issue 9
September 2018
ISSN 0021-972X
EISSN 1945-7197

Volume 103, Issue 9, September 2018

Print and Online

Case Reports

Matti L Gild and others
The Journal of Clinical Endocrinology & Metabolism, Volume 103, Issue 9, September 2018, Pages 3119–3123, https://doi.org/10.1210/jc.2018-01074

Biallelic-inactivating mutations in the glucagon receptor cause glucagon cell hyperplasia and neoplasia, also termed Mahvash syndrome. We report a case of GCHN presenting with hypercalcemia.

Taher Modarressi and others
The Journal of Clinical Endocrinology & Metabolism, Volume 103, Issue 9, September 2018, Pages 3124–3130, https://doi.org/10.1210/jc.2018-01181

A rare combination of gestational gigantomastia and PTHrP-mediated hypercalcemia, with resolution of hypercalcemia after termination of pregnancy, suggests an underexplored placenta-breast axis.

Mini-Reviews

Teresa Vanessa Fiorentino and others
The Journal of Clinical Endocrinology & Metabolism, Volume 103, Issue 9, September 2018, Pages 3131–3143, https://doi.org/10.1210/jc.2018-00468

In this review, we describe the findings of several studies showing that 1-h-PG ≥155 mg/dL can identify individuals at increased risk of diabetes among subjects with NGT.

Katrien Clotman and others
The Journal of Clinical Endocrinology & Metabolism, Volume 103, Issue 9, September 2018, Pages 3144–3154, https://doi.org/10.1210/jc.2018-00728

We reviewed the literature about programmed cell death-1 (PD-1) inhibitor–induced type 1 diabetes mellitus. Fasting or random plasma glucose and HbA1c levels should be tested at each administration.

Michael H Guo and others
The Journal of Clinical Endocrinology & Metabolism, Volume 103, Issue 9, September 2018, Pages 3155–3168, https://doi.org/10.1210/jc.2018-01126

This review discusses the findings of GWAS of height, including the identification of relevant biological pathways and implications for growth disorders and height prediction.

Clinical Research Articles

Laura A Marlow and others
The Journal of Clinical Endocrinology & Metabolism, Volume 103, Issue 9, September 2018, Pages 3169–3182, https://doi.org/10.1210/jc.2017-01845

We generated seven new thyroid cell lines as well as 10 PDTX mouse models. We discuss methodology and describe optimal criteria for creating patient tumor tissue–derived preclinical thyroid cancer models.

E Michael Lewiecki and others
The Journal of Clinical Endocrinology & Metabolism, Volume 103, Issue 9, September 2018, Pages 3183–3193, https://doi.org/10.1210/jc.2017-02163

Romosozumab—an antisclerostin antibody—treatment in men with osteoporosis for 12 months led to significantly greater gains in spine, femoral neck, and hip BMD than placebo and was well tolerated.

Diana L Alba and others
The Journal of Clinical Endocrinology & Metabolism, Volume 103, Issue 9, September 2018, Pages 3194–3204, https://doi.org/10.1210/jc.2017-02301

Here, we show that BMI does not mark adiposity in Chinese-Americans but instead that subcutaneous fat fibrosis correlates with both visceral obesity and reduced glucose control in this population.

Thach Tran and others
The Journal of Clinical Endocrinology & Metabolism, Volume 103, Issue 9, September 2018, Pages 3205–3214, https://doi.org/10.1210/jc.2017-02656

Excess mortality was found for 10 years after hip fractures and approximately 5 years after virtually all proximal and lower leg fractures in this nationwide registry-based follow-up study.

David Neil and others
The Journal of Clinical Endocrinology & Metabolism, Volume 103, Issue 9, September 2018, Pages 3215–3224, https://doi.org/10.1210/jc.2017-02644

We studied several doses of GKS2881078 in older healthy males and females for up to 56 days. GSK2881078 was well tolerated and produced dose-dependent increases in muscle mass.

Thomas W Laver and others
The Journal of Clinical Endocrinology & Metabolism, Volume 103, Issue 9, September 2018, Pages 3225–3230, https://doi.org/10.1210/jc.2017-02662

PLIN1 frameshift variants were reported to cause lipodystrophy. We investigated sequencing data from over 140,000 people and established that null variants in PLIN1 do not cause lipodystrophy.

Seung Eun Lee and others
The Journal of Clinical Endocrinology & Metabolism, Volume 103, Issue 9, September 2018, Pages 3231–3238, https://doi.org/10.1210/jc.2017-02774

In this large-scale, population-based study, we found that having diabetic retinopathy was an independent risk factor for the development of Parkinson disease.

Herjan J T Coelingh Bennink and others
The Journal of Clinical Endocrinology & Metabolism, Volume 103, Issue 9, September 2018, Pages 3239–3249, https://doi.org/10.1210/jc.2018-00147

The fetal estrogen estetrol (E4) in healthy men shows promise as a safe and effective drug for use in prostate cancer.

Luciana Audi Castroneves and others
The Journal of Clinical Endocrinology & Metabolism, Volume 103, Issue 9, September 2018, Pages 3250–3259, https://doi.org/10.1210/jc.2018-00193

In a prospective study, 68Ga PET/CT in medullary thyroid cancer was not superior to currently used imaging studies, except in bone. Expression of SSTR did not correlate with 68Ga-DOTATATE uptake.

Daniel Popp and others
The Journal of Clinical Endocrinology & Metabolism, Volume 103, Issue 9, September 2018, Pages 3260–3266, https://doi.org/10.1210/jc.2018-00187

Pancreatic fat, body fat distribution, and metabolic parameters were measured in women with and without a history of GDM. Pancreatic fat did not correlate with β-cell function.

Josephine Lund-Nielsen and others
The Journal of Clinical Endocrinology & Metabolism, Volume 103, Issue 9, September 2018, Pages 3267–3277, https://doi.org/10.1210/jc.2018-00250

Genetically determined plasma 25-hydroxyvitamin D was not associated with either Crohn disease or ulcerative colitis in a Mendelian randomization study of 120,013 individuals.

Janice B Schwartz and others
The Journal of Clinical Endocrinology & Metabolism, Volume 103, Issue 9, September 2018, Pages 3278–3288, https://doi.org/10.1210/jc.2018-00295

Free 25(OH)D levels were affected by clinical conditions as well as by race, BMI, and DBP haplotype. Relationships between free and total 25(OH)D were affected only by clinical conditions and BMI.

Garrett Strizich and others
The Journal of Clinical Endocrinology & Metabolism, Volume 103, Issue 9, September 2018, Pages 3289–3298, https://doi.org/10.1210/jc.2018-00356

Multivariable-adjusted analysis in a diverse sample of Hispanic/Latino youth revealed associations between SB and risk factors for diabetes and cardiovascular disease, independent of BMI.

Laura Stirm and others
The Journal of Clinical Endocrinology & Metabolism, Volume 103, Issue 9, September 2018, Pages 3299–3309, https://doi.org/10.1210/jc.2018-00397

GDM elevates saturated fatty acids in maternal plasma and the placenta and contributes independently of BMI to placental inflammation that is not transmitted to the fetus.

Huei-Kai Huang and others
The Journal of Clinical Endocrinology & Metabolism, Volume 103, Issue 9, September 2018, Pages 3310–3318, https://doi.org/10.1210/jc.2018-00408

We found that hypothyroidism was independently associated with a higher risk of all-cause mortality in older patients and that thyroxine replacement therapy was associated with decreased mortality risk.

Yuanjun Lyu and others
The Journal of Clinical Endocrinology & Metabolism, Volume 103, Issue 9, September 2018, Pages 3319–3330, https://doi.org/10.1210/jc.2018-00422

We analyzed data of 219,522 Chinese patients with type 2 diabetes and found that there were large variations in the prevalence and risks of coronary heart disease and stroke in T2DM in China.

Richard D Semba and others
The Journal of Clinical Endocrinology & Metabolism, Volume 103, Issue 9, September 2018, Pages 3331–3339, https://doi.org/10.1210/jc.2018-00480

The relationship of plasma metabolites with altered glucose metabolism was characterized in 472 older adults. Altered glucose metabolism was associated with 4 amino acids and 16 lipid species.

Jiayun Shen and others
The Journal of Clinical Endocrinology & Metabolism, Volume 103, Issue 9, September 2018, Pages 3340–3349, https://doi.org/10.1210/jc.2018-00490

Patients with GIOP and vertebral fracture have a significant reduction in total vBMD and cortical thinning, which may help identify high-risk patients considered to have low fracture risk as assessed by DXA or FRAX.

Ruben H Willemsen and others
The Journal of Clinical Endocrinology & Metabolism, Volume 103, Issue 9, September 2018, Pages 3350–3358, https://doi.org/10.1210/jc.2018-00500

Frequent C-peptide measurements in subjects with newly diagnosed type 1 diabetes through the use of dried blood spots at home provide a convenient and reliable method for monitoring β-cell function.

Marlen Vitales-Noyola and others
The Journal of Clinical Endocrinology & Metabolism, Volume 103, Issue 9, September 2018, Pages 3359–3367, https://doi.org/10.1210/jc.2018-00498

T regulatory type 1 cells, a subpopulation of Treg cells with a potent suppressive effect, are significantly decreased and exhibit a diminished suppressive function in autoimmune thyroid disorders.

Albert Shieh and others
The Journal of Clinical Endocrinology & Metabolism, Volume 103, Issue 9, September 2018, Pages 3368–3375, https://doi.org/10.1210/jc.2018-00515

During vitamin D repletion, early rise in free, but not total, 25(OH)D was associated with changes in markers of 25(OHD) entry into kidney and parathyroid cells, suggesting a role for free 25(OH)D.

Keun Young Cheon and others
The Journal of Clinical Endocrinology & Metabolism, Volume 103, Issue 9, September 2018, Pages 3376–3385, https://doi.org/10.1210/jc.2018-00549

MISRII/AMHRII is expressed in both granulosa and theca cells; this indicates that MIS/AMH, produced in the granulosa cells, is active in the theca cells as well.

Jose A Rosa-Parra and others
The Journal of Clinical Endocrinology & Metabolism, Volume 103, Issue 9, September 2018, Pages 3386–3393, https://doi.org/10.1210/jc.2018-00550

Cortisol plays an important role in metabolic processes. It could influence body composition, affecting anthropometric indicators such as weight and height in early childhood.

Julie Abildgaard and others
The Journal of Clinical Endocrinology & Metabolism, Volume 103, Issue 9, September 2018, Pages 3394–3404, https://doi.org/10.1210/jc.2018-00554

Cross-sectional study of 55 women aged 45 to 60 years. For a given fat mass, postmenopausal women showed increased ectopic lipid deposition and insulin resistance compared with premenopausal women.

Yi Liu and others
The Journal of Clinical Endocrinology & Metabolism, Volume 103, Issue 9, September 2018, Pages 3405–3410, https://doi.org/10.1210/jc.2018-00558

In this study, we used CT to investigate vBMD in patients receiving ESI. We found that patients treated with ESI had lower vBMD compared with age- and sex-matched controls.

Freek J H Sorgdrager and others
The Journal of Clinical Endocrinology & Metabolism, Volume 103, Issue 9, September 2018, Pages 3411–3419, https://doi.org/10.1210/jc.2018-00582

Hydrocortisone treatment affected symptoms of fatigue and physical functioning by altering tryptophan metabolism in patients with secondary adrenal insufficiency.

Sasha R Howard and others
The Journal of Clinical Endocrinology & Metabolism, Volume 103, Issue 9, September 2018, Pages 3420–3429, https://doi.org/10.1210/jc.2018-00646

A damaging mutation in HS6ST1 was found to cause familial self-limited delayed puberty (DP), and heterozygous Hs6st1 loss produced DP in mice. Mutations in other GnRH deficiency genes were not seen.

Huicui Meng and others
The Journal of Clinical Endocrinology & Metabolism, Volume 103, Issue 9, September 2018, Pages 3430–3438, https://doi.org/10.1210/jc.2018-00667

Compared with simple and unrefined carbohydrate–enriched diets, refined carbohydrate resulted in the least favorable lipid profile but had little effect on other cardiometabolic indicators.

Shu-Man Lin and others
The Journal of Clinical Endocrinology & Metabolism, Volume 103, Issue 9, September 2018, Pages 3439–3448, https://doi.org/10.1210/jc.2018-00652

We found that statin use was associated with a decreased risk of osteoporosis, hip fracture, and vertebral fracture in stroke patients, with a dose-effect relationship observed.

Shanlee M Davis and others
The Journal of Clinical Endocrinology & Metabolism, Volume 103, Issue 9, September 2018, Pages 3449–3455, https://doi.org/10.1210/jc.2018-00682

In this randomized, placebo-controlled study, low-dose oxandrolone in prepubertal boys with Klinefelter syndrome leads to earlier puberty but does not impair testicular hormone production.

Kieren J Mather and others
The Journal of Clinical Endocrinology & Metabolism, Volume 103, Issue 9, September 2018, Pages 3456–3465, https://doi.org/10.1210/jc.2018-00712

In PET studies, liraglutide did not alter myocardial fuel selection in metformin-treated T2D. This argues against a myocardial metabolic effect in cardiovascular disease benefits of GLP-1 treatments.

Fahim Ebrahimi and others
The Journal of Clinical Endocrinology & Metabolism, Volume 103, Issue 9, September 2018, Pages 3466–3476, https://doi.org/10.1210/jc.2018-00739

In this randomized, double-blind, placebo-controlled trial treatment with the IL-1 receptor antagonist anakinra increased testosterone levels in obese male patients with low testosterone.

Kosuke Inoue and others
The Journal of Clinical Endocrinology & Metabolism, Volume 103, Issue 9, September 2018, Pages 3477–3485, https://doi.org/10.1210/jc.2018-00738

Plasma aldosterone concentration was highly suppressed by dexamethasone in KCNJ5-mutated aldosterone-producing adenomas, indicating potential hyperresponsiveness to endogenous ACTH in such adenomas.

Janice Mayne and others
The Journal of Clinical Endocrinology & Metabolism, Volume 103, Issue 9, September 2018, Pages 3486–3495, https://doi.org/10.1210/jc.2018-00777

sLDLRs correlated positively and strongly with TGs and moderately with LDL-C in this cross-sectional study of 273 white Canadians. Loss-of-function in PCSK9 affected the correlation with LDL-C.

Amit Pandya and others
The Journal of Clinical Endocrinology & Metabolism, Volume 103, Issue 9, September 2018, Pages 3496–3502, https://doi.org/10.1210/jc.2018-00792

A total of 1997 thyroid nodules were assigned a 2015 ATA category and compared with cytopathology. The positive predictive value for cancer increased by category; however, a number of biopsies were needed to detect a single cancer.

Commentaries

Chinmay S Marathe and others
The Journal of Clinical Endocrinology & Metabolism, Volume 103, Issue 9, September 2018, Pages 3503–3506, https://doi.org/10.1210/jc.2018-00849
Joanna Klubo-Gwiezdzinska and Leonard Wartofsky
The Journal of Clinical Endocrinology & Metabolism, Volume 103, Issue 9, September 2018, Pages 3507–3510, https://doi.org/10.1210/jc.2018-01081

This paper is a commentary on the study by Livhits et al. addressing the relative utility of two molecular diagnostic techniques for thyroid nodules indeterminate on FNA cytology.

Matthew R Brown and Aleksey V Matveyenko
The Journal of Clinical Endocrinology & Metabolism, Volume 103, Issue 9, September 2018, Pages 3511–3513, https://doi.org/10.1210/jc.2018-01245

Chronotherapeutic glucocorticoid replacement modulates clock gene expression.

Murat Bastepe
The Journal of Clinical Endocrinology & Metabolism, Volume 103, Issue 9, September 2018, Pages 3514–3515, https://doi.org/10.1210/jc.2018-01340

A new gain-of-function CASR mutation has been described as a cause of hypocalcemia. This mutation, unlike other such mutations, is inherited recessively and has implications in genetic evaluation.

Letters to the Editor

Andreas Machens and Henning Dralle
The Journal of Clinical Endocrinology & Metabolism, Volume 103, Issue 9, September 2018, Pages 3516–3517, https://doi.org/10.1210/jc.2018-00906
Clare Turnbull and others
The Journal of Clinical Endocrinology & Metabolism, Volume 103, Issue 9, September 2018, Pages 3518–3519, https://doi.org/10.1210/jc.2018-01094
Carolina Castillo-Castro and others
The Journal of Clinical Endocrinology & Metabolism, Volume 103, Issue 9, September 2018, Page 3520, https://doi.org/10.1210/jc.2018-00884
Liv Guro Engen Hanem and others
The Journal of Clinical Endocrinology & Metabolism, Volume 103, Issue 9, September 2018, Page 3521, https://doi.org/10.1210/jc.2018-01114

Print Abstracts—Full Content Online Only

Clinical Research Articles

Abel Decmann and others
The Journal of Clinical Endocrinology & Metabolism, Volume 103, Issue 9, September 2018, Pages 3522–3530, https://doi.org/10.1210/jc.2018-00817

miRNAs are significantly different between AML and adrenocortical tumors. hsa-miR-451a is overexpressed in AML, but there is no significant difference in hsa-miR-483-5p in AML vs ACC.

Emma J Hamilton and others
The Journal of Clinical Endocrinology & Metabolism, Volume 103, Issue 9, September 2018, Pages 3531–3539, https://doi.org/10.1210/jc.2018-00850

In a 10-year longitudinal study in T1D, there was evidence that reduced bone mineral density occurred early in males but then stabilized whereas it remained normal throughout in females.

Elise M Philips and others
The Journal of Clinical Endocrinology & Metabolism, Volume 103, Issue 9, September 2018, Pages 3540–3547, https://doi.org/10.1210/jc.2018-00855

In a longitudinal birth cohort study, we observed associations between total bisphenols and phthalic acid with a longer TTP in women lacking preconceptional folic acid supplementation.

Arash Derakhshan and others
The Journal of Clinical Endocrinology & Metabolism, Volume 103, Issue 9, September 2018, Pages 3548–3556, https://doi.org/10.1210/jc.2018-00890

We studied the reference ranges and determinants of thyroid function (TSH, free and total T4 and T3) during early pregnancy and found associations between tobacco smoke exposure and thyroid function.

Christine E Cherella and others
The Journal of Clinical Endocrinology & Metabolism, Volume 103, Issue 9, September 2018, Pages 3557–3565, https://doi.org/10.1210/jc.2018-00895

This study addresses important gaps in knowledge about the risk of malignancy, outcomes, and optimal interval of surveillance of cytologically benign thyroid nodules in children.

Sri Harsha Tella and others
The Journal of Clinical Endocrinology & Metabolism, Volume 103, Issue 9, September 2018, Pages 3566–3573, https://doi.org/10.1210/jc.2018-00918

Based on data on adrenocortical carcinoma from a national cancer registry, we conclude that predictors of survival include tumor stage and grade and comorbid conditions.

Henriette Ejlsmark-Svensson and others
The Journal of Clinical Endocrinology & Metabolism, Volume 103, Issue 9, September 2018, Pages 3574–3583, https://doi.org/10.1210/jc.2018-00923

All patients with PHPT were identified over a 10-year period, and the prevalence and predictors of renal function and calcifications were assessed.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close